At list price, Ozempic runs ~$969–$998/month and Wegovy about $1,349/month — but almost nobody uninsured pays list. Both have NovoCare self-pay prices below that, laid out in the table below. Prices change often — confirm current NovoCare pricing.
Both contain semaglutide, but they are approved for different uses: Ozempic for type 2 diabetes, Wegovy for weight management and heart risk. That decides insurance more than price does, and which one fits you is your prescriber’s call. Compounded semaglutide runs about $99–$300/month (the low end is a 12-month plan billed upfront) and is not FDA-approved. Estimates as of September 2026.